EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Anti-inflammatory benefits of semaglutide: State of the art

Habib Yaribeygi, Mina Maleki, Tannaz Jamialahmadi, Amirhossein Sahebkar

Journal of Clinical & Translational Endocrinology · 2024-06 · 36 · 100340

DOI: 10.1016/j.jcte.2024.100340 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical & Translational Endocrinology, 2024-06. Verfasst von Habib Yaribeygi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Physiology, Semnan University of Medical Sciences, Semnan, Iran. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Individuals with diabetes often have chronic inflammation and high levels of inflammatory cytokines, leading to insulin resistance and complications. Anti-inflammatory agents are proposed to prevent these issues, including using antidiabetic medications with anti-inflammatory properties like semaglutide, a GLP-1 analogue. Semaglutide not only lowers glucose but also shows potential anti-inflammatory effects. Studies suggest it can modulate inflammatory responses and benefit those with diabetes. However, the exact mechanisms of its anti-inflammatory effects are not fully understood. This review aims to discuss the latest findings on semaglutide's anti-inflammatory effects and the potential pathways involved.

Schlagwörter

Stichwörter der Autor:innen

Diabetes mellitusGLP-1InflammationInsulin resistanceSemaglutide

Autor:innen und Institutionen

  • Research Center of Physiology, Semnan University of Medical Sciences, Semnan, Iran.
  • Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Medical Toxicology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.

Zitieren

APA

Yaribeygi, H., Maleki, M., Jamialahmadi, T., & Sahebkar, A. (2024). Anti-inflammatory benefits of semaglutide: State of the art. Journal of Clinical & Translational Endocrinology, 36, 100340. https://doi.org/10.1016/j.jcte.2024.100340

Vancouver

Yaribeygi H, Maleki M, Jamialahmadi T, Sahebkar A. Anti-inflammatory benefits of semaglutide: State of the art. Journal of Clinical & Translational Endocrinology. 2024;36:100340. doi:10.1016/j.jcte.2024.100340

BibTeX
@article{Yaribeygi2024,
  author = {Yaribeygi, Habib and Maleki, Mina and Jamialahmadi, Tannaz and Sahebkar, Amirhossein},
  title = {Anti-inflammatory benefits of semaglutide: State of the art},
  journal = {Journal of Clinical & Translational Endocrinology},
  year = {2024},
  volume = {36},
  pages = {100340},
  doi = {10.1016/j.jcte.2024.100340}
}
Kostenlos starten →